A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL.
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to CLL
Related studies linked through entity extraction aliases.
Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
- Status
- UNKNOWN
- Phase
- N/A
A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- WITHDRAWN
- Phase
- N/A
Impact of Treatment With Targeted Therapies on the Generation of CAR T Cells in CLL Patients
- Status
- UNKNOWN
- Phase
- NA
CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- N/A
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hypertension Management in Cancer Patients
- Status
- TERMINATED
- Phase
- NA
Acalabrutinib and Venetoclax Treatment of Newly Diagnosed Patients With CLL at High Risk of Infection or Early Treatment
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Chronic Lymphocytic Leukemia Electronic Patient Reported Outcomes Study
- Status
- COMPLETED
- Phase
- N/A
Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Registry of the German CLL Study Group
- Status
- RECRUITING
- Phase
- N/A
Peptide-drug-conjugates for Personalized, Targeted Therapy of Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- N/A
Heavy Light Chain in Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- N/A